125 related articles for article (PubMed ID: 12198211)
1. Prognostic factors in mesangioproliferative glomerulonephritis.
Vikse BE; Bostad L; Aasarød K; Lysebo DE; Iversen BM
Nephrol Dial Transplant; 2002 Sep; 17(9):1603-13. PubMed ID: 12198211
[TBL] [Abstract][Full Text] [Related]
2. Clinical prognostic factors in biopsy-proven benign nephrosclerosis.
Vikse BE; Aasarød K; Bostad L; Iversen BM
Nephrol Dial Transplant; 2003 Mar; 18(3):517-23. PubMed ID: 12584273
[TBL] [Abstract][Full Text] [Related]
3. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
4. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk.
Little MA; Dupont P; Campbell E; Dorman A; Walshe JJ
Kidney Int; 2006 Feb; 69(3):504-11. PubMed ID: 16395262
[TBL] [Abstract][Full Text] [Related]
5. IgA-dominant glomerulonephritis with a membranoproliferative pattern of injury.
Andeen NK; Jefferson JA; Akilesh S; Alpers CE; Bissonnette ML; Finn LS; Higgins J; Houghton DC; Kambham N; Magil A; Najafian B; Nicosia RF; Troxell ML; Smith KD
Hum Pathol; 2018 Nov; 81():272-280. PubMed ID: 30420049
[TBL] [Abstract][Full Text] [Related]
6. IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Néphrologues de l'Est.
Frimat L; Briançon S; Hestin D; Aymard B; Renoult E; Huu TC; Kessler M
Nephrol Dial Transplant; 1997 Dec; 12(12):2569-75. PubMed ID: 9430853
[TBL] [Abstract][Full Text] [Related]
7. Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis.
Piccoli A; Codognotto M; Tabbi MG; Favaro E; Rossi B
Nephrol Dial Transplant; 2010 Aug; 25(8):2583-9. PubMed ID: 20200005
[TBL] [Abstract][Full Text] [Related]
8. Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis.
Cansick JC; Lennon R; Cummins CL; Howie AJ; McGraw ME; Saleem MA; Tizard EJ; Hulton SA; Milford DV; Taylor CM
Nephrol Dial Transplant; 2004 Nov; 19(11):2769-77. PubMed ID: 15385635
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in immunoglobulin-A nephropathy.
Muthukumar T; Fernando ME; Jayakumar M
J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461
[TBL] [Abstract][Full Text] [Related]
10. Pathological regression by angiotensin II type 1 receptor blockade in patients with mesangial proliferative glomerulonephritis.
Ohtake T; Oka M; Maesato K; Mano T; Ikee R; Moriya H; Kobayashi S
Hypertens Res; 2008 Mar; 31(3):387-94. PubMed ID: 18497456
[TBL] [Abstract][Full Text] [Related]
11. Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis.
Takei T; Itabashi M; Moriyama T; Shimizu A; Tsuruta Y; Ochi A; Nakayama K; Iwasaki C; Uchida K; Nitta K
Clin Exp Nephrol; 2013 Feb; 17(1):92-8. PubMed ID: 22821391
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of immunoglobulin-associated mesangiocapillary glomerulonephritis: A South African experience.
Chothia MY; Panday AS; Coetzee L; Bates W
Nephrology (Carlton); 2020 Oct; 25(10):765-774. PubMed ID: 32463170
[TBL] [Abstract][Full Text] [Related]
14. "Benign" hypertensive nephrosclerosis.
Dasgupta I; Porter C; Innes A; Burden R
QJM; 2007 Feb; 100(2):113-9. PubMed ID: 17244670
[TBL] [Abstract][Full Text] [Related]
15. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
16. Outcome of patients with primary immune-complex type mesangiocapillary glomerulonephritis (MCGN) in Cape Town South Africa.
Okpechi IG; Dlamini TA; Duffield M; Rayner BL; Moturi G; Swanepoel CR
PLoS One; 2014; 9(11):e113302. PubMed ID: 25411791
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of membranoproliferative glomerulonephritis under a new classification.
Nargund P; Kambham N; Mehta K; Lafayette RA
Clin Nephrol; 2015 Dec; 84(6):323-30. PubMed ID: 26445002
[TBL] [Abstract][Full Text] [Related]
18. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases.
Schmitt H; Bohle A; Reineke T; Mayer-Eichberger D; Vogl W
Nephron; 1990; 55(3):242-50. PubMed ID: 2370922
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
